News

Icon revises 2025 guidance amid elevated cancellations and strategic investments
Explore ICON plc's Q1 2025 earnings call insights, reflecting challenges in clinical trials, operational innovations, and adjusted guidance.
Zacks Investment Research on MSN4d
ICON's Q1 Earnings Surpass Estimates, Revenues Lag, Stock Down
ICON plc ICLR posted first-quarter 2025 adjusted earnings per share of $3.19, down 8.1% from the year-ago period’s reported figure. However, the metric surpassed the Zacks Consensus Estimate by 3.5%.